Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
How do you approach treating a patient with RA and cirrhosis who did not respond to csDMARDs?
Related Questions
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Do you combine methotrexate and leflunomide for the treatment of RA?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
